Independent report

Accelerated access pathways for medical technologies

Proposals for accelerated access pathways for medicines, diagnostics, medical devices and digital products.


Accelerated Access Review Proposition 2: Getting ahead of the curve - Recommendations for accelerated access pathways and a flexible pricing and reimbursement framework

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.


This report brings together feedback from over 150 stakeholders to recommend ways to improve the UK environment for innovation and estimates how much earlier medicines could be available to patients if these recommendations were followed.

It sets out a flexible reimbursement framework that seeks to balance affordability and budget predictability with risk-sharing around outcomes.

The findings are part of a wide-ranging evidence base that will inform the work of the Accelerated Access Review.

Published 22 March 2016